Ankerstar Wealth’s Integra LifeSciences IART Stock Holding History

Ankerstar Wealth’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10	Closed	-$124	–	1016
2025 Q4	$124	Buy	+10	New	+$133	﹤0.01%	980

Other funds holding IART

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ankerstar Wealth's IART Position: Q1 2026 in Review

Ankerstar Wealth sold out of Integra LifeSciences (IART) in Q1 2026, closing a stake of 10 shares — an estimated $124 sold.

Ankerstar Wealth first reported a position in IART in Q4 2025 and held it in 1 quarter. The position peaked at $124 in Q4 2025. 202 funds tracked by Wall St. Rank hold IART as of Q1 2026.

Ankerstar Wealth reported no remaining Integra LifeSciences position as of Q1 2026 after selling out during the quarter.
Ankerstar Wealth sold 10 Integra LifeSciences shares in Q1 2026, an estimated $124.
Ankerstar Wealth first reported a position in Integra LifeSciences in Q4 2025 and held it in 1 quarter.
Ankerstar Wealth's Integra LifeSciences position peaked at $124 in Q4 2025.
202 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Ankerstar Wealth's 13F filing for Q1 2026, filed 14 May 2026.